NDC codes

FDA NDC Directory
Product NDC (as listed)0093-3547Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00093-3547Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0093-3547-560009335475630 CAPSULE in 1 BOTTLE (0093-3547-56)Marketed from May 30, 2017

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Atomoxetine
Generic name (nonproprietary)
atomoxetine
Active ingredients
Atomoxetine hydrochloride — 80 mg/1
Dosage form
Capsule
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 079022
Marketing start
Listing expires
Other FDA classes
Norepinephrine Uptake Inhibitors (Mechanism)
Identifiers
Product ID 0093-3547_8f789887-a198-4965-8582-e973d4da3994SPL ID 8f789887-a198-4965-8582-e973d4da3994
Pharmacologic class
Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093354756 followed by a unit qualifier and the quantity

Package 00093-3547-56. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 079022

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 079022
ProductStrengthForm · routeLabelerProduct NDC
AtomoxetineAtomoxetine hydrochloride 60 mg/1CapsuleOralA-S Medication Solutions50090-6254
AtomoxetineAtomoxetine hydrochloride 100 mg/1CapsuleOralTeva Pharmaceuticals USA, Inc.0093-3548
AtomoxetineAtomoxetine hydrochloride 40 mg/1CapsuleOralA-S Medication Solutions50090-6289
AtomoxetineAtomoxetine hydrochloride 25 mg/1CapsuleOralAvKARE42291-066
AtomoxetineAtomoxetine hydrochloride 10 mg/1CapsuleOralAvKARE42291-064
AtomoxetineAtomoxetine hydrochloride 18 mg/1CapsuleOralAvKARE42291-065
AtomoxetineAtomoxetine hydrochloride 100 mg/1CapsuleOralAvKARE42291-070
AtomoxetineAtomoxetine hydrochloride 40 mg/1CapsuleOralAvKARE42291-067
AtomoxetineAtomoxetine hydrochloride 60 mg/1CapsuleOralAvKARE42291-068
AtomoxetineAtomoxetine hydrochloride 80 mg/1CapsuleOralAvKARE42291-069
AtomoxetineAtomoxetine hydrochloride 80 mg/1CapsuleOralA-S Medication Solutions50090-6511
AtomoxetineAtomoxetine hydrochloride 25 mg/1CapsuleOralA-S Medication Solutions50090-6512
AtomoxetineAtomoxetine hydrochloride 10 mg/1CapsuleOralTeva Pharmaceuticals USA, Inc.0093-3542
AtomoxetineAtomoxetine hydrochloride 18 mg/1CapsuleOralTeva Pharmaceuticals USA, Inc.0093-3543
AtomoxetineAtomoxetine hydrochloride 25 mg/1CapsuleOralTeva Pharmaceuticals USA, Inc.0093-3544
AtomoxetineAtomoxetine hydrochloride 40 mg/1CapsuleOralTeva Pharmaceuticals USA, Inc.0093-3545
AtomoxetineAtomoxetine hydrochloride 60 mg/1CapsuleOralTeva Pharmaceuticals USA, Inc.0093-3546

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in
Atomoxetine NDC 0093-3547 | Med-Code